Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 346

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Tocotrienol: a review of its therapeutic potential

Theriault, Andre, Chao, Jun-Tzu, Wang, Qi, Gapor, Abdul, Adeli, Khosrow·1999·Clinical Biochemistry
DOI 10.1016/s0009-9120(99)00027-2
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0009-9120(99)00027-2

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 85

  1. Kamal-Eldin, 1996, The chemistry and antioxidant properties of tocopherols and tocotrienols, Lipids, 31, 671, 10.1007/BF02522884 · DOI · Paper page
  2. Ames, 1995, The cause and prevention of cancer, Proc Natl Acad Sci USA, 2, 5258, 10.1073/pnas.92.12.5258 · DOI · Paper page
  3. Carroll KK, Cuthrie N, Nesaretnam K, Gapor A, Chambers AF. Anti-cancer properties of tocotrienols from palm oil. In: Ong ASH, Niki E, Packer L, Eds. Nutrition, lipids, health, and disease. Pp. 117–21. Champaign, IL: AOCS Press, 1996.
  4. 1984, The lipid research clinics coronary primary prevention trial results I, JAMA, 251, 351, 10.1001/jama.251.3.351 · DOI · Paper page
  5. Stampfer, 1993, Vitamin E consumption and the risk of coronary disease in women, N Engl J Med, 328, 1444, 10.1056/NEJM199305203282003 · DOI · Paper page
  6. Rimm, 1993, Vitamin E consumption and the risk of coronary heart disease in man, N Engl J Med, 328, 1450, 10.1056/NEJM199305203282004 · DOI · Paper page
  7. Hodis, 1995, Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis, JAMA, 273, 1849, 10.1001/jama.273.23.1849 · DOI
  8. Kushi, 1996, Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women, N Engl J Med, 334, 1156, 10.1056/NEJM199605023341803 · DOI · Paper page
  9. Esterbauer, 1991, Role of vitamin E in preventing the oxidation of low-density lipoprotein, Am J Clin Nutr, 3, 314S, 10.1093/ajcn/53.1.314S · DOI · Paper page
  10. Salonen, 1992, Autoantibody against oxidized LDL and progression of carotid atherosclerosis, Lancet, 339, 883, 10.1016/0140-6736(92)90926-T · DOI · Paper page
  11. Salonen, 1985, Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease, Am J Cardiol, 56, 226, 10.1016/0002-9149(85)90839-2 · DOI · Paper page
  12. Kok, 1987, Serum selenium, vitamin antioxidants and cardiovascular mortality, Am J Clin Nutr, 45, 462, 10.1093/ajcn/45.2.462 · DOI
  13. Hense, 1993, Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels, Atherosclerosis, 103, 21, 10.1016/0021-9150(93)90036-T · DOI
  14. Qureshi, 1991, Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee), Am J Clin Nutr, 53, 1021S, 10.1093/ajcn/53.4.1021S · DOI · Paper page
  15. Qureshi, 1995, Response of hypercholesterolemic subjects to administration of tocotrienols, Lipids, 30, 1171, 10.1007/BF02536620 · DOI
  16. Qureshi, 1997, Novel tocotrienols of rice bran modulate cardiovascular disease risk parameters of hypercholesterolemic humans, Nutr Biochem, 8, 290, 10.1016/S0955-2863(97)89667-2 · DOI
  17. Tomeo, 1995, Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis, Lipids, 30, 1179, 10.1007/BF02536621 · DOI
  18. Qureshi, 1986, The structure of an inhibitor of cholesterol biosynthesis isolated from barley, J Biol Chem, 261, 10544, 10.1016/S0021-9258(18)67419-8 · DOI · Paper page
  19. Correll, 1994, Identification of farnesol as the non-sterol derivative of mevalonic acid required for the accelerated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, J Biol Chem, 269, 17390, 10.1016/S0021-9258(17)32450-X · DOI
  20. Qureshi, 1991, Dietary tocotrienols reduce concentrations of plasma cholesterol, apolipoprotein B, thromboxane B2, and platelet factor 4 in pigs with inherited hyperlipidemias, Am J Clin Nutr, 53, 1042S, 10.1093/ajcn/53.4.1042S · DOI
  21. Pearce, 1992, Hypocholesterolemic activity of synthetic and natural tocotrienols, J Med Chem, 35, 3595, 10.1021/jm00098a002 · DOI · Paper page
  22. Pearce, 1992, Inhibitors of cholesterol biosynthesis. 2. Hypocholesterolemic and antioxidant activities of benzopyran and tetrahydroaphthalene analogues of the tocotrienols, J Med Chem, 37, 526, 10.1021/jm00030a012 · DOI
  23. Qureshi, 1996, Dietary α-tocopherol attenuates the impact of γ-tocotrienol on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in chickens, J Nutr, 126, 389, 10.1093/jn/126.2.389 · DOI
  24. Albers, 1989, Apoprotein measurements and their clinical application in cholesterol screening, Clin Lab Med, 34, B4
  25. Sniderman, 1980, Association of coronary atherosclerosis with hyperbetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low-density (beta) lipoproteins], Proc Natl Acad Sci USA, 77, 604, 10.1073/pnas.77.1.604 · DOI · Paper page
  26. Bestehorn, 1997, The effect of simvastatin on progression of coronary artery disease, Eur Heart J, 18, 226, 10.1093/oxfordjournals.eurheartj.a015224 · DOI
  27. Parker, 1993, Tocotrienols regulate cholesterol production in mammalian cells by post-transcriptional suppression of 3-Hydroxy-3-methylglutaryl-coenzyme A reductase, J Biol Chem, 268, 11230, 10.1016/S0021-9258(18)82115-9 · DOI · Paper page
  28. Wang, 1998, Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B, Biochem Biophys Res Commun, 246, 640, 10.1006/bbrc.1998.8677 · DOI
  29. Theriault, 1999, Effects of γ-tocotrienol on apolipoprotein B synthesis, degradation, and secretion in HepG2 cells, Arterioscler Thromb Vasc Biol, 19, 704, 10.1161/01.ATV.19.3.704 · DOI
  30. Maher, 1995, Lipoprotein(a) and coronary heart disease, Curr Opin Lipidol, 6, 229, 10.1097/00041433-199508000-00007 · DOI
  31. Scanu, 1990, Lipoprotein(a), J Clin Invest, 86, 1709, 10.1172/JCI114625 · DOI · Paper page
  32. Naruszewicz, 1992, Oxidative modification of lipoprotein(a) and the effect of β-carotene, Metabolism, 41, 1215, 10.1016/0026-0495(92)90012-Y · DOI
  33. Miles, 1989, A potential basis for the thrombotic risks associated with lipoprotein(a), Nature, 339, 301, 10.1038/339301a0 · DOI · Paper page
  34. Yamaguchi, 1994, Effectiveness of LDL-apheresis in preventing restenosis after percutaneous transluminal coronary angioplasty (PTCA), Chem Phys Lipids, 67/68, 399, 10.1016/0009-3084(94)90162-7 · DOI
  35. Kanemitsu, 1994, Effects of LDL apheresis on restenosis after angioplasty, Chem Phys Lipids, 67/68, 339, 10.1016/0009-3084(94)90155-4 · DOI
  36. Jenner, 1993, Effects of age, sex, and menopausal status on plasma lipoprotein(a) levels, Circulation, 87, 607, 10.1161/01.CIR.87.4.1135 · DOI · Paper page
  37. Brewer HB. Effectiveness of diet and drugs in the treatment of patients with elevated Lp(a) levels. In: Scanu AM. Ed. Lipoprotein(a). Pp. 211–20. New York: Academic Press, 1990. · DOI
  38. Carlson, 1989, Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidemic subjects treated with nicotinic acid, J Intern Med, 226, 271, 10.1111/j.1365-2796.1989.tb01393.x · DOI · Paper page
  39. Pelegri, 1992, Effect of bezafibrate on lipoprotein(a) and triglyceride-rich lipoproteins, including intermediate-density lipoproteins, in patients with chronic renal failure receiving haemodialysis, Nephrol Dial Transplant, 7, 623, 10.1093/ndt/7.7.623 · DOI
  40. Farmer, 1995, Currently available hypolipidaemic drugs and future therapeutic developments, Baillieres Clin Endocrinol Metab, 9, 825, 10.1016/S0950-351X(95)80177-4 · DOI
  41. Hirsh, 1987, Hyperactive platelets and complications of coronary artery disease, N Engl J Med, 316, 1543, 10.1056/NEJM198706113162410 · DOI
  42. Jandak, 1989, α-Tocopherol, an effective inhibitor of platelet adhesion, Blood, 73, 141, 10.1182/blood.V73.1.141.141 · DOI
  43. Romach, 1993, Effects of RRR-alpha-tocopheryl succinate on IL-1 and PGE2 production by macrophages, Nutr Cancer, 20, 205, 10.1080/01635589309514288 · DOI
  44. Meydani, 1993, Modulation by dietary vitamin E and selenium of clotting whole blood thromboxane A2 and aortic prostacyclin synthesis in rats, Nutr Biochem, 4, 322, 10.1016/0955-2863(93)90076-9 · DOI
  45. Douglas, 1986, Vitamin E inhibits platelet phospholipase A2, Biochem Biophys Acta, 876, 639, 10.1016/0005-2760(86)90053-6 · DOI
  46. Traber, 1995, Vitamin E, Am J Clin Nutr, 62, 1501S, 10.1093/ajcn/62.6.1501S · DOI · Paper page
  47. Appleby, 1994, Structure of the human cyclo-oxygenase-2 gene, Biochem J, 302, 723, 10.1042/bj3020723 · DOI · Paper page
  48. Steiner, 1995, Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks, Am J Clin Nutr, 62, 1381S, 10.1093/ajcn/62.6.1381S · DOI
  49. Niki, 1985, Effect of phytyl side chain of vitamin E on its antioxidant activity, J Biol Chem, 260, 2191, 10.1016/S0021-9258(18)89536-9 · DOI
  50. Burton, 1989, Vitamin E as in vitro and in vivo antioxidant, Ann NY Acad Sci, 570, 7, 10.1111/j.1749-6632.1989.tb14904.x · DOI · Paper page
  51. Burton, 1990, Vitamin E, Ann Rev Nut, 10, 357, 10.1146/annurev.nu.10.070190.002041 · DOI · Paper page
  52. Steinberg, 1989, Beyond cholesterol, N Engl J Med, 320, 915, 10.1056/NEJM198904063201407 · DOI · Paper page
  53. Verlangeri, 1992, Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis, J Am Coll Nutr, 11, 131, 10.1080/07315724.1992.12098234 · DOI
  54. Reaven, 1993, Effect of dietary antioxidant combinations in humans, Arterioscler Thromb, 13, 590, 10.1161/01.ATV.13.4.590 · DOI · Paper page
  55. Burton, 1983, Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?, Arch Biochem Biophys, 221, 281, 10.1016/0003-9861(83)90145-5 · DOI · Paper page
  56. Cooney, 1993, γ-Tocopherol detoxification of nitrogen dioxide, Proc Natl Acad Sci USA, 90, 1771, 10.1073/pnas.90.5.1771 · DOI · Paper page
  57. Serbinova, 1991, Free radical recycling and intramembrane mobility in the antioxidant properties of α-tocopherol and α-tocotrienol, Free Radic Biol Med, 10, 263, 10.1016/0891-5849(91)90033-Y · DOI · Paper page
  58. Suzuki, 1993, Structural and dynamic membrane properties of α-tocopherol and α-tocotrienol, Biochemistry, 32, 10692, 10.1021/bi00091a020 · DOI · Paper page
  59. Kamat, 1995, Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria, Neuro Lett, 195, 179, 10.1016/0304-3940(95)11812-B · DOI
  60. Serbinova, 1992, Palm oil vitamin E protects against ischemia/reperfusion injury in the isolated perfused Langendorff heart, Nutr Res, 12, S203, 10.1016/S0271-5317(05)80464-6 · DOI
  61. Carlos, 1994, Leukocyte-Endothelial adhesion molecules, Blood, 84, 2068, 10.1182/blood.V84.7.2068.2068 · DOI · Paper page
  62. Peter, 1997, Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin, Arterioscler Thromb Vasc Biol, 17, 505, 10.1161/01.ATV.17.3.505 · DOI · Paper page
  63. Blann, 1994, Circulating endothelial cell leukocyte adhesion molecules in atherosclerosis, Thromb Haemost, 74, 151
  64. Schreck, 1992, Nuclear factor κB, Free Radic Res Commun, 17, 221, 10.3109/10715769209079515 · DOI · Paper page
  65. Khan, 1995, Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells, J Clin Invest, 95, 1262, 10.1172/JCI117776 · DOI · Paper page
  66. Cominacini, 1997, Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidizied LDL on human umbilical vein endothelial cells, Free Radic Biol Med, 22, 117, 10.1016/S0891-5849(96)00271-7 · DOI · Paper page
  67. Birt, 1986, Update on the effects of vitamin A, C and E, and selenium on carcinogenesis, Proc Soc Exp Biol Med, 183, 311, 10.3181/00379727-183-42424 · DOI
  68. Bostick, 1993, Reduced risk of colon cancer with high intake of vitamin E, Cancer Res, 53, 4230
  69. Taylor, 1994, Prevention of eosophageal cancer, Cancer Res, 54, 2029S
  70. Watkins, 1993, γ-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets, Lipids, 28, 1113, 10.1007/BF02537079 · DOI
  71. Komiyama, 1989, Studies on the biological activity of tocotrienols, Chem Pharm Bull, 37, 1369, 10.1248/cpb.37.1369 · DOI
  72. Wan Ngah, 1991, Effect of tocotrienols on hepatocarcinogenesis induced by 2-acetylaminofluorene in rats, Am J Clin Nutr, 53, 1076S, 10.1093/ajcn/53.4.1076S · DOI
  73. Rahmat, 1993, Long-term administration of tocotrienols and tumor-marker enzyme activities during hepatocarcinogenesis in rats, Nutrition, 9, 229
  74. Nesaretnam, 1995, Effect of tocotrienols on the growth of a human breast cancer cell line in culture, Lipids, 30, 1139, 10.1007/BF02536615 · DOI
  75. Guthrie, 1997, Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination, J Nutr, 127, 544S, 10.1093/jn/127.3.544S · DOI
  76. Nesaretnam, 1998, Tocotrienols inhibit the growth of human breast cancer cells irrespectively of estrogen receptor status, Lipids, 33, 461, 10.1007/s11745-998-0229-3 · DOI
  77. Turley, 1992, RRR-tocopheryl succinate modulation of human promyelocytic leukemia (HL-60) cell proliferation and differentiation, Nutr Cancer, 18, 201, 10.1080/01635589209514221 · DOI
  78. Charpentier, 1993, RRR-tocopheryl succinate inhibits proliferation and enhances secretion of transforming growth factor-β (TGF-β) by human breast cancer cells, Nutr Cancer, 19, 225, 10.1080/01635589309514254 · DOI
  79. Crowell, 1991, Selective inhibition of isoprenylation of 21-26-kDa proteins by the anticarcinogen d-limonene and its metabolites, J Biol Chem, 266, 17679, 10.1016/S0021-9258(19)47425-5 · DOI · Paper page
  80. Elson, 1994, The chemoprevention of cancer by mevalonate-derived constituents of fruits and vegetables, J Nutr, 124, 607, 10.1093/jn/124.5.607 · DOI
  81. Larner, 1998, A phase I-II trial of lovastatin for anaplastic astrocytoma and glioblastoma multiforme, Am J Clin Oncol, 21, 579, 10.1097/00000421-199812000-00010 · DOI
  82. Stone, 1997, Tocopherols and the etiology of colon cancer, J Natl Cancer Inst, 89, 1006, 10.1093/jnci/89.14.1006 · DOI
  83. Christen, 1997, γ-Tocopherol traps mutagenic electrophiles such as NOx and complements α-tocopherol, Proc Natl Acad Sci USA, 94, 3217, 10.1073/pnas.94.7.3217 · DOI · Paper page
  84. Packer, 1979, Direct observation of a free radical interaction between vitamin E and vitamin C, Nature, 278, 737, 10.1038/278737a0 · DOI · Paper page
  85. Gould, 1991, A comparison of tocopherol and tocotrienol for the chemoprevention of chemically induced rat mammary tumors, Am J Clin Nutr, 53, 1068S, 10.1093/ajcn/53.4.1068S · DOI

Cited by

See all 346

Metadata

Authors
Theriault, A., Chao, J.-T., Wang, Q., Gapor, A., & Adeli, K.
Venue
Clinical Biochemistry
Publisher
Elsevier BV
Published
1999-07
Volume
32
Issue
5
Pages
309-319
ISSN
0009-9120 (ISSN-L)
DOI
10.1016/s0009-9120(99)00027-2
OpenAlex
W2017729853
Cited by
346
References
7
FWCI
3.89
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tocotrienol: a review of its therapeutic potential. https://app.cochat.ai/papers/10.1016/s0009-9120(99)00027-2
The paper
Theriault, A., Chao, J.-T., Wang, Q., Gapor, A., & Adeli, K. (1999). Tocotrienol: a review of its therapeutic potential. Clinical Biochemistry. https://doi.org/10.1016/s0009-9120(99)00027-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.